BioNexus Gene Lab (BGLC)
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, ae...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- 1.550
- Volume
- 482
- Turnover
- 716.96
- Avg Price
- 1.487
- Bid/Ask Ratio
- 24.81%
- Amplitude
- --
- 52wk High
- 6.100
- Volume Ratio
- 0.10
- Turnover Ratio
- 0.03%
News
- TradingView · Aug 14 at 04:36 PM
Su-Leng Tan Lee Discloses Investment at BioNexus Gene Lab Corp with 11.5% Stake
- PUBT · Aug 14 at 04:07 PM
BioNexus Q2 FY26 net loss narrows 53.51% to $286,451; revenue drops 96.63% to $76,156 vs year-ago quarter
- PUBT · Aug 7 at 03:28 PM
BioNexus Gene Lab files initial beneficial ownership statement for Fidelion Diagnostics Pte. Ltd
- PUBT · Jul 31 at 04:01 PM
BioNexus Gene Lab names CFO Chong Set Fui in initial beneficial ownership filing
- PUBT · Jul 28 at 08:00 AM
BioNexus advances VitaGuard Southeast Asia rollout after China hospital visits
- benzinga_article · Jul 28 at 07:05 AM
12 Industrials Stocks Moving In Tuesday's Pre-Market Session
